Enveric Biosciences receives US patent for psychiatric treatment methods

Go back to Enveric Biosciences receives US patent for psychiatric treatment methods
(NASDAQ: ENVB) Delayed: 1.32 -0.02 (1.49%)
Previous Close $1.34    52 Week High
Open $1.31    52 Week Low
Day High $1.34    P/E N/A 
Day Low $1.25    EPS
Volume 118,060